Reference : Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of th...
Scientific journals : Article
Life sciences : Microbiology
http://hdl.handle.net/2268/76181
Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes.
English
Donofrio, Gaetano [> > > >]
Sartori, Chiara [> > > >]
Ravanetti, Lara [> > > >]
Cavirani, Sandro [> > > >]
Gillet, Laurent mailto [Université de Liège - ULiège > > Immunologie et vaccinologie >]
Vanderplasschen, Alain mailto [Université de Liège - ULiège > > Immunologie et vaccinologie >]
Taddei, Simone [> > > >]
Flammini, Cesidio Filippo [> > > >]
2007
BMC Biotechnology
BioMed Central
7
68
Yes (verified by ORBi)
International
1472-6750
London
England
[en] Animals ; Diarrhea Viruses, Bovine Viral/physiology ; Genetic Vectors/genetics ; Herpesvirus 4, Bovine/genetics ; Immunization/methods ; Rabbits ; Sheep ; Transfection/methods ; Viral Envelope Proteins/genetics/immunology
[en] BACKGROUND: The biological characteristics of BoHV-4 make it a good candidate as a gene delivery vector for vaccination purposes. These characteristics include little or no pathogenicity, unlikely oncogenicity, the capability to accommodate large amounts of foreign genetic material, the ability to infect several cell types from different animal species, and the ability to maintain transgene expression in both undifferentiated and differentiated cells. RESULTS: A recombinant bovine herpesvirus 4 (BoHV-4CMV-IgKE2-14 Delta TK) expressing an enhanced secreted form of the bovine viral diarrhea virus (BVDV) structural glycoprotein E2 (gE2-14), obtained by the removal of the putative transmembrane domain and addition of a 14 amino acids peptide at its carboxyl terminal and an immunoglobulin K signal peptide to the amino terminal, was successfully constructed using a Recombineering (recombination -mediated genetic engineering) approach on BoHV-4 cloned as bacterial artificial chromosome. The galactokinase - based recombineering system was modified by the introduction of a kanamycin expression cassette and a kanamycin selection step that allowed a significant reduction of the untargeted background clones. BoHV-4CMV-IgKE2-14 Delta TK infected cell lines highly expressed gE2-14, which maintained native antigenic properties in a serum neutralization inhibition test. When rabbits and sheep were immunized with BoHV-4CMV-IgKE2-14 Delta TK, high levels of serum neutralized antibodies against BVDV were generated. CONCLUSION: This work highlights the engineerization of BoHV-4 genome as a vector for vaccine purposes and may provide the basis for BVDV vaccination exploiting the BoHV-4- based vector that delivers an improved secreted version of the BVDV structural glycoprotein E2.
Researchers ; Professionals
http://hdl.handle.net/2268/76181
also: http://hdl.handle.net/2268/29081
10.1186/1472-6750-7-68

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
BMC 2007 7 68.pdfPublisher postprint1.01 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.